Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2021-04-01 Audit Report / Informat…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
Application Proof (1st submission)
Audit Report / Information Classification · 95% confidence The document is an 'Application Proof' for Transcenta Holding Limited, which is a standard term used in the Hong Kong Stock Exchange (HKEX) for a preliminary prospectus or listing document. It contains sections typical of an IPO filing, such as 'Industry overview', 'Business', 'Financial information', and 'Accountants' report'. Since it is an announcement of the availability of these documents for a listing process, and it does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS). FY 2020
2021-04-01 English
Application Proof (1st submission)
Regulatory Filings Classification · 95% confidence The document is titled as an "Application Proof" and contains multiple disclaimers stating it is a draft, incomplete, and subject to change. It is explicitly stated that this document is not a prospectus or an offering document and is for information purposes only. The document references the Stock Exchange of Hong Kong Limited and the Securities and Futures Commission, indicating it is related to a listing or public offering process. The content includes sections such as expected timetable, summary, risk factors, business overview, corporate structure, financial information, and appendices including an accountants' report and pro forma financial information. This structure and content are typical of a listing document or prospectus draft submitted for regulatory review prior to an IPO or public offering. It is not a final report, earnings release, or management discussion but a draft application proof for listing. Given the nature of the document as a draft application proof for listing and the disclaimers, it does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is best classified under Regulatory Filings (RNS) as a general regulatory announcement and filing related to the listing application process, which is a fallback category for filings that do not fit other specific categories.
2021-04-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.